Literature DB >> 235666

Dailysate calcium and plasma calcium fractions during and after haemodialysis.

C Fuchs, M Brasche, U Donath-Wolfram, J Kubosch, E Quellhorst, F Scheler.   

Abstract

Dialysate calcium and plasma calcium fractions during and after haemodialysis: The effect of differenct dialysate Ca concentrations on the plasma Ca fractions was examined in 28 patients. In 10 patients dialysed with a dialysate Ca concentration of 3.0 mEq/l the Ca fractions were determined at the start and end of dialysis. 8 patients were dialysed with dialysate with dialysate Ca of 3.5 mEq/l. In this group the Ca fractions were also estimated in the dialysis-free interval. The third group was dialysed with a dialysate Ca of 4.5 mEq/l. Total calcium and protein-bound calcium rose significantly in all groups. Ionised calcium in the first group was significantly reduced, in the second group it remained constant and in the third group it was significantly raised. Since parathyroid function depends on the plasma ionised calcium it is concluded that a dialysed concentration of 3.0 mEq/l is partly responsible for the pathogenesis of secondary hyperparathyroidism and of renal osteodystophy. In normocalcaemic patients a dialysate Ca concentration of 3.5 to 4.0 mEq/l is optimal. In patients entering long-term haemodialysis treatment with pronounced calcium deficiency symptoms a dialysate Ca of up to 4.5 mEq/l may be indicated for a short period after having normalized the inorganic phosphate levels in order to prevent extraosseous calcification.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 235666     DOI: 10.1007/bf01466855

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  20 in total

Review 1.  The kidney as an endocrine organ involved in calcium homeostasis.

Authors:  H F DeLuca
Journal:  Kidney Int       Date:  1973-08       Impact factor: 10.612

2.  The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease.

Authors:  E Slatopolsky; N S Bricker
Journal:  Kidney Int       Date:  1973-08       Impact factor: 10.612

3.  [Studies on intestinal 47 Calcium absorption in healthy subjects and patients with chronic renal failure as well as on the significance of vitamin D 3 or 25-hydroxycholecalciferol therapy in renal osteopathy].

Authors:  R D Hesch; W Gerlach; H V Henning; D Emrich; F Scheler; R Kattermann
Journal:  Dtsch Med Wochenschr       Date:  1972-11-10       Impact factor: 0.628

4.  Role of dialysate calcium concenration in osteoporosis in patients on haemodialysis.

Authors:  J M Bone; A M Davison; J S Robson
Journal:  Lancet       Date:  1972-05-13       Impact factor: 79.321

5.  Hyperaluminaemia from aluminum resins in renal failure.

Authors:  G M Berlyne; J Ben-Ari; D Pest; J Weinberger; M Stern; R Levine; G R Gilmore
Journal:  Lancet       Date:  1970-09-05       Impact factor: 79.321

6.  Rarity of renal osteodystrophy in Israel due to low phosphorus intake. A natural experiment.

Authors:  G M Berlyne; J Ben-Arie; N Epstein; E M Booth; R Yagil
Journal:  Nephron       Date:  1973       Impact factor: 2.847

7.  Role of phosphate depletion and high dialysate calcium in controlling dialytic renal osteodystrophy.

Authors:  R S Goldsmith; W J Johnson
Journal:  Kidney Int       Date:  1973-08       Impact factor: 10.612

8.  [Determination of ionized calcium in serum with an ion-selective flow-thru-electrode. Method and normal values].

Authors:  C Fuchs; K Paschen; P G Spieckermann; C von Westberg
Journal:  Klin Wochenschr       Date:  1972-09-01

9.  Regulation of the plasma ionized calcium and its therapeutic control in patients treated by regular hemodialysis.

Authors:  M Kaye; G F Cohen; G Chatterjee; R Mangel
Journal:  Trans Am Soc Artif Intern Organs       Date:  1969

10.  Control of secondary hyperparathyroidism during long-term hemodialysis.

Authors:  R S Goldsmith; J Furszyfer; W J Johnson; A E Fournier; C D Arnaud
Journal:  Am J Med       Date:  1971-05       Impact factor: 4.965

View more
  1 in total

1.  [Calcium and phosphate metabolism in hemofiltration (author's transl)].

Authors:  C Fuchs; D Dorn; H V Henning; D Matthaei; C McIntosh; P Kramer; D Ritter; B Schünemann; F Scheler
Journal:  Klin Wochenschr       Date:  1978-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.